Last reviewed · How we verify
NCT06366880
Parenteral Nutrition Cycling for Prevention of Cholestatic Syndrome in Newborn
NA trial testing Parenteral nutrition cycling in Cholestasis in Newborn in 66 participants. Currently enrolling.
15 December 2024
Quick facts
| Lead sponsor | Hospital Pediátrico de Sinaloa |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 66 |
| Start date | 11 March 2024 |
| Primary completion | 15 December 2024 |
| Estimated completion | 15 December 2025 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Parenteral nutrition cycling
Conditions studied
- Cholestasis in Newborn — all drugs for Cholestasis in Newborn →
Sponsor
Hospital Pediátrico de Sinaloa
Who can join
Adults 1 Hour to 28 Days, any sex, with Cholestasis in Newborn. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Despite the use of parenteral nutrition cycling (PNC) in neonatal intensive care units (NICU), there is limited evidence regarding the benefits in relation to the nutrición parenteral total (NPT) in term and late preterm infants. The recommendations from the recently published Latin American Society of Gastroenterology, Hepatology and Pediatric Nutrition guidelines are substantially different in this area, and surveys have reported variations in clinical practice. The aim of this randomised controlled trial (RCT) is to evaluate the benefits and risks of PNC AND parenteral nutrition total (NPT) in term and late preterm infants.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06366880
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06366880 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Pediátrico de Sinaloa
- Last refreshed: 16 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06366880.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing